Subscribe to our newsletter

Rheumatoid Arthritis Registry

CorEvitas is now part of Thermo Fisher Scientific. Read More.

The CorEvitas Rheumatoid Arthritis Registry is the largest RA real world prospective cohort study in the world. We collect data from both physicians and patients at the time of a clinical encounter and longitudinally thereafter.


Clinical outcome measures and PROs in the CorEvitas Rheumatoid Arthritis Registry.

Among the variables we collect, some of the key outcome measures to inform your RA research include:

Calculated Outcomes

Patient Reported Outcomes

Registry Scientific Advisors

Picture of Jeff Greenberg, MD, MPH

Jeff Greenberg, MD, MPH

Chief Medical Officer, CorEvitas | Attending Physician, Institute for Rheumatic Diseases, Atlantic Health System

Picture of Dimitrios Pappas, MD, MPH

Dimitrios Pappas, MD, MPH

Assistant Professor of Medicine, Columbia University College of Physicians and Surgeons | Director, Division of Rheumatology, Athens Medical Center, Athens, Greece

Picture of Joshua F. Baker, MD, MSCE

Joshua F. Baker, MD, MSCE

Associate Professor of Medicine (Rheumatology) at the Hospital of the University of Pennsylvania and the Veteran's Administration Medical Center | Associate Professor of Epidemiology in Biostatistics and Epidemiology

Picture of Leslie Harrold, MD, MPH

Leslie Harrold, MD, MPH

Chief Scientific Officer, CorEvitas | Associate Professor of Medicine, University of Massachusetts 

Picture of Stanley B. Cohen, MD 

Stanley B. Cohen, MD 

Clinical Associate Professor, University of Texas Southwestern Medical School  | Director, Arthritis division of the Health South Rehabilitation Center, TX